| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3346926 | Diagnostic Microbiology and Infectious Disease | 2015 | 4 Pages |
Abstract
Most research in sub-Saharan Africa establishes hepatitis B infection via one-time hepatitis B surface antigen (HBsAg) testing. Of 237 HIV-infected patients from two clinical trials testing HBsAg positive (MiniVidas®), 206 (86.9%) had validated serological tests using another assay (Architect). Discrepancies could be due to inactive infection, highlighting the importance of assessing hepatitis B virus infection phase.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Anders Boyd, Sarah Maylin, Raoul Moh, Delphine Gabillard, Hervé Menan, Nadia Mahjoub, Christine Danel, Xavier Anglaret, Serge Paul Eholié, Pierre-Marie Girard, Fabien Zoulim, Constance Delaugerre, Karine Lacombe,